Search
EXCITE clinical trial abstract
Excimer laser randomized controlled study for the treatment of femoropopliteal in-stent restenosisiFR: Proven outcomes. Superior value.
Philips is dedicated to the advancement of physiology guided PCI. Since the introduction of hyperemia-free iFR modality in 2014, iFR has been studied in nearly 15,000 patients and used in over 4,000 cath labs around the world.Philips Volcano Chronic Venous Disease (CVD): Early Diagnosis Can Lead to Better Results
Chronic Venous Disease or CVD occurs when the blood in your legs cannot flow back to your heart. When this happens, pooling blood can raise pressure in your veins, causing a range of problems.In-service for Phoenix atherectomy system
In-service for Phoenix atherectomy systemParikh Turbo-Elite case study - bilateral SFA CTO
Case study: recanalization of bilateral CTOs in the SFA with Dr. Ashisk ParikhThe Growing Need for Lead Management
A new era in lead management; managing leads and leading change.LACI datasheet
Limb salvage following laser-assisted angioplasty for CLI: results of the LACI multicenter trialTightRail™ SUB-C ROTATING DILATOR SHEATH
TightRail™ Sub-C Rotating Dilator Sheath completes Spectranetics’ portfolio of mechanical devices for lead extraction. Sub-C is specifically designed for the challenges of the subclavian region, including vessel entry when fibrosis and calcium are presentLLD® Lead Locking Device: stability, flexibility, visibility.
LLD EZ and LLD E combine the best of the original LLD family and enhanced tip design with new ease-of-use features to provide a flexible traction solution for leads targeted for removal today.Steinkamp datasheet
To evaluate the safety and long-term results after laser and angioplasty of short occlusions of the SFAIntraSight, Interventional Applications Platform: Physiology & IVUS
Smart. Simple. Seamless. Optimizing lab performance.Philips Bridge Occlusion Balloon Best Practices Protocol
The Philips Bridge Occlusion Balloon best practices protocol is the consensus of 30 high-volume extracting physicians for the deployment of Bridge.